| Literature DB >> 33402980 |
Hans-Ullrich Voelker1, Laura Poetzl1, Annette Strehl1, Hans-Konrad Mueller-Hermelink2, Ansgar Stuefe3, Gerhard Stauch4.
Abstract
BACKGROUND/Entities:
Keywords: Telepathology; ipath; low income country; paediatric
Mesh:
Year: 2020 PMID: 33402980 PMCID: PMC7751540 DOI: 10.4314/ahs.v20i3.37
Source DB: PubMed Journal: Afr Health Sci ISSN: 1680-6905 Impact factor: 0.927
Overall distribution of cases to anatomic sites and diagnostic groups (n=486)
| Anatomic sites | n | Diagnostic groups | n |
| Abdomen | 9 | ||
| Bone | 23 | Benign tumor | 73 |
| Breast | 53 | Fibroadenoma | 36 |
| Colon | 22 | Fibrotic changes | 25 |
| Eye | 13 | Hirshsprung disease | 7 |
| Fluid | 5 | Non-specific inflammation | 103 |
| Head&Neck | 39 | Non-specific lymphadenitis | 66 |
| Kidney | 8 | Physiological tissue | 12 |
| Lymph node | 116 | Reactive benign conditions (e.g. abortus, mastopathia) | 39 |
| Ovary | 14 | Schistosomiasis | 4 |
| Skin | 83 | Tuberculosis | 25 |
| Soft tissue | 75 | ||
| Testis | 14 | Adenocarcinoma | 8 |
| Thyroid | 2 | Kaposi sarcoma | 5 |
| Urinary bladder | 5 | Lymphoma | 31 |
| Uterine cervix | 2 | Other malignant tumors | 8 |
| Uterus | 3 | Retinoblastoma | 7 |
| Sarcoma | 27 | ||
| Sex cord stroma tumor | 5 | ||
| Squamous cell carcinoma | 5 |
The five most frequent anatomic sites and the two most frequent diagnoses of benign and malignant diseases
| Benign diseases | |
| Lymph node (n=96) | Non-specific lymphadenitis n=66 |
| Skin (n=73) | Non-specific inflammation n=32 |
| Soft tissue (n=63) | Non-specific inflammation n=24 |
| Breast (n=52) | Fibroadenoma n=36 |
| Head&Neck (n=27) | Non-specific inflammation n=11 |
| Lymph node (n=20) | Lymphoma n=19 |
| Soft tissue (n=13) | Sarcoma n=10 |
| Head&Neck (n=12) | Adenocarcinoma n=6 |
| Skin (n=10) | Squamous cell carcinoma n=3 |
| Ovary (n=10) | Lymphoma n=4 |
Figure 1Subtypes of benign tumors (left) and reactive benign conditions (right)
Concordance of diagnoses primarily investigated by telepathology (TP) with a second opinion (SO) in Germany. Diagnostic evaluation: 1-completely identical diagnosis between TP and SO, 2-mild discordances (e.g. in subtype of inflammation or grading of cancer), 3-identical in benign/malignant group, but other entity of disease, 4-Diagnosis of TP was false malignant, 5-diagnosis of TP was false benign, 6- primary diagnosis by TP was not possible
| Sent for | Kind of | n/% | Number of cases in | |
| 390 | 107 | 1 | 50 (46.7%) | S: 14, IHC 3 |
| 2 | 23 (21.4%) | S: 8, IHC: 3 | ||
| 3 | 22 (20.5%) | S: 11, IHC: 7 | ||
| 4 | 6 (5.6%) | S: 3, IHC: 1 | ||
| 5 | 0 | |||
| 6 | 6 (5.6%) | S: 3 | ||
| 96 | 72 | 1 | 21 (29.1%) | S: 1, IHC: 17 |
| 2 | 16 (22.2%) | S: 1, IHC: 14 | ||
| 3 | 18 (25.0%) | IHC: 18 | ||
| 4 | 0 | |||
| 5 | 11 (15.3%) | S: 2, IHC: 9 | ||
| 6 | 6 (8.3%) | IHC: 3 |
Figure 2Subtypes of sarcomas (left) and lymphomas (right)